Eye surgery aftermath: new tool measures corneal strength changes
NCT ID NCT06818461
First seen Jun 25, 2026 · Last updated Jul 02, 2026 · Updated 4 times
Summary
This study measured how three common eye surgeries—LASIK, PRK, and corneal cross-linking (CXL)—change the stiffness of the cornea. Using a device called Corvis ST, researchers assessed 150 adults who had undergone one of these procedures at least a month earlier. The goal was to better understand how these surgeries affect corneal biomechanics, which could help improve surgical safety and outcomes.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better predict and prevent complications like corneal weakening after refractive surgery.
- What could go wrong
- This is a small, completed observational study, not a treatment trial. The findings may not apply to all patients or change current practice.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Participants
-
150 people
The number who actually took part.
- Started
-
Jan 2025
- Finished
-
Oct 2025
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
Who is studied
patients coming for refractive surgery
- Ages
-
18 to 60 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: \- 1. Adults aged 18-60 years. 2. Patients who have undergone LASIK, PRK, or CXL at least 1 month prior to measure-ment. 3\. Stable refraction for at least 3 months post-procedure. 4. No evidence of active ocular disease or infection. Exclusion Criteria: * 1\. History of other ocular surgeries (excluding LASIK, PRK, or CXL). 2. Presence of keratoconus or other corneal ectatic disorders not treated with CXL. 3\. Systemic or ocular conditions affecting corneal biomechanical properties (e.g., dia-betes, connective tissue disorders). 4\. Current or recent use of medications influencing corneal biomechanics.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Keratoconus are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clearvision
Mohandessin, Giza Governorate, 11344, Egypt
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Two lens designs go Head-to-Head for aging eyes
- Can AI protect Kids' eyesight where eye doctors are scarce?
- Shorter eye treatment put to the test against standard crosslinking
- Two toric lenses go head to head in vision test
- Eye scans as a window to the body: study probes retinal imaging across diseases
- Shorter UV treatment for keratoconus put to the test